Intelliheart tests in Amcal pharmacies
Friday, 13 June, 2008
IM Medical (ASX: IMI) has reached an exclusive agreement with Sigma Pharmaceuticals that will see the Intelliheart cardiac risk assessment tests sold through Sigma's Amcal network.
The Amcal network includes over 700 Amcal, Amcal Max and Guardian pharmacies throughout the country.
The product will initially be rolled out to over 200 pharmacies throughout Victoria in July. Stores in other states will begin stocking the product in the next few months.
Under the agreement Sigma has the right to produce and market other products using the Intelliheart brand name.
Intelliheart is the only widely available diagnostic which tests for both heart rate variability and arterial stiffness.
TGA approves donanemab for treatment of early Alzheimer's
The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...
Ultra-processed foods linked to poor health, premature death
Evidence suggests a dose-response relationship between ultra-processed food consumption and...
Shorter radiotherapy course proves safe for prostate cancer
A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...
